Renalytix Plc (RNLX)

NASDAQ: RNLX · IEX Real-Time Price · USD
0.860
-0.050 (-5.49%)
At close: Mar 28, 2024, 3:58 PM
0.869
+0.009 (1.01%)
After-hours: Mar 28, 2024, 7:28 PM EDT

Total Valuation

Renalytix has a market cap or net worth of $54.56 million. The enterprise value is $57.43 million.

Market Cap 54.56M
Enterprise Value 57.43M

Important Dates

The last earnings date was Wednesday, February 14, 2024, after market close.

Earnings Date Feb 14, 2024
Ex-Dividend Date n/a

Share Statistics

Renalytix has 49.97 million shares outstanding.

Shares Outstanding 49.97M
Owned by Insiders (%) 4.66%
Owned by Institutions (%) 8.64%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 22.64
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 23.83
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.59

Current Ratio 0.59
Quick Ratio 0.50
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -1,071.90% and return on invested capital (ROIC) is -7,269.13%.

Return on Equity (ROE) -1,071.90%
Return on Assets (ROA) -165.30%
Return on Capital (ROIC) -7,269.13%
Revenue Per Employee $23,627
Profits Per Employee -$410,284
Employee Count 102
Asset Turnover 0.10
Inventory Turnover n/a

Taxes

In the past 12 months, Renalytix has paid $7,000 in taxes.

Income Tax 7,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -60.37% in the last 52 weeks. The beta is 1.92, so Renalytix's price volatility has been higher than the market average.

Beta (1Y) 1.92
52-Week Price Change -60.37%
50-Day Moving Average 0.75
200-Day Moving Average 1.47
Relative Strength Index (RSI) 48.05
Average Volume (30 Days) 1,993,968

Short Selling Information

Short Interest 894,619
Short Previous Month 500,571
Short % of Shares Out 1.52%
Short % of Float n/a
Short Ratio (days to cover) 0.43

Income Statement

In the last 12 months, Renalytix had revenue of $2.41 million and -$41.85 million in losses. Loss per share was -$0.90.

Revenue 2.41M
Gross Profit 152,000
Operating Income -38.38M
Pretax Income -41.84M
Net Income -41.85M
EBITDA -41.25M
EBIT -41.84M
Loss Per Share -$0.90
Full Income Statement

Balance Sheet

The company has $5.62 million in cash and $8.48 million in debt, giving a net cash position of -$2.87 million or -$0.06 per share.

Cash & Cash Equivalents 5.62M
Total Debt 8.48M
Net Cash -2.87M
Net Cash Per Share -$0.06
Equity / Book Value -7.96M
Book Value Per Share -0.16
Working Capital -5.67M
Full Balance Sheet

Cash Flow

Operating Cash Flow -36.16M
Capital Expenditures n/a
Free Cash Flow -36.16M
FCF Per Share -$0.74
Full Cash Flow Statement

Margins

Gross margin is 6.31%, with operating and profit margins of -1,592.57% and -1,736.47%.

Gross Margin 6.31%
Operating Margin -1,592.57%
Pretax Margin -1,736.18%
Profit Margin -1,736.47%
EBITDA Margin -1,711.45%
EBIT Margin -1,736.18%
FCF Margin -1,500.29%

Dividends & Yields

Renalytix does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -29.88%
Shareholder Yield -29.88%
Earnings Yield -76.70%
FCF Yield -66.27%

Analyst Forecast

The average price target for Renalytix is $4.25, which is 394.19% higher than the current price. The consensus rating is "Strong Buy".

Price Target $4.25
Price Target Difference 394.19%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Renalytix has an Altman Z-Score of -35.39 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -35.39
Piotroski F-Score 3